Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells

H Vliagoftis1, A Schwingshackl, C D Milne

  • 1Pulmonary Research Group, the Departments Medicine University of Calgary, Calgary, Alberta, Canada.

Abstract

Insights

Proteinase-activated receptor-2 (PAR-2) activation in airway epithelial cells upregulates matrix metalloproteinase-9 (MMP-9) production, a key factor in airway remodeling. Corticosteroids inhibit this process, suggesting PAR-2

Area of Science:

  • Cellular biology
  • Molecular biology
  • Respiratory medicine

Background:

  • Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling.
  • Proteinase-activated receptor-2 (PAR-2) is expressed in epithelial cells and activated by proteases, implicated in inflammation.
  • PAR-2 activation may influence airway inflammation and remodeling.

Purpose of the Study:

  • To investigate the impact of PAR-2 activation on matrix metalloproteinase-9 (MMP-9) production in airway epithelial cells.
  • To explore the signaling pathways involved in PAR-2-mediated MMP-9 release.
  • To assess the effect of anti-inflammatory agents on this process.

Main Methods:

  • Human airway epithelial cell lines (A549) and primary cells (SAEC) were stimulated with PAR-2 activating peptides and trypsin.
  • Messenger RNA (mRNA) expression of MMP-2 and MMP-9 was analyzed using RT-PCR.
  • MMP-2 and MMP-9 enzymatic activity was measured by gelatin zymography.
  • Involvement of MAP kinase and NF-kappaB pathways was assessed using specific inhibitors.
  • Effects of dexamethasone, budesonide, and indomethacin were evaluated.

Main Results:

  • PAR-2 activation significantly upregulated MMP-9 mRNA and enzymatic activity, but not MMP-2.
  • Dexamethasone and budesonide inhibited PAR-2-mediated MMP-9 release.
  • MMP-9 release was independent of prostaglandin synthesis.
  • MAP kinase (MEK-1) and NF-kappaB signaling pathways were crucial for PAR-2-mediated MMP-9 release.
  • Trypsin induced MMP-9 and MMP-2 release.

Conclusions:

  • PAR-2 plays a significant role in regulating MMP-9 release from airway epithelial cells.
  • PAR-2 mediated MMP-9 production is a potential target for therapeutic intervention in airway inflammatory diseases.
  • These findings highlight the importance of PAR-2 in airway tissue remodeling associated with conditions like asthma.

Related Concept Videos

The Extracellular Matrix01:42

The Extracellular Matrix

In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.Composition of the Extracellular MatrixThe extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse molecules.
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...